Abstract
Actual and potential fibrin-stabilizing factor (FSF) activity in the blood plasma of children in various are groups and in adults was estimated. Differences in blood plasma activities regarding desmofibrin formation were revealed, which depended upon the changes in enzyme concentration varying with age and upon the changes in thiol group concentration.
Similar content being viewed by others
Literature
Ambrus, C. M., Ambrus, J. L., Niswander, K. R., Weintraub, D. H., Bross, I. D. J., Lassman, H. B.: Changes in fibrin-stabilizing factor levels in relation to maternal hemorrhage and neonatal disease. Pediat. Res. 4, 82–88 (1970).
Baggett, R. T., Hampton, J. W., Bird, R. M.: Fibrinolytic bleeding complicated by factor XIII defect. Arch. intern. Med. 121, 539–544 (1968).
Balsamo, V., Corso, D., Mancuso, G.: Osservazioni sul comportamento del fattore stabilizzante fibrinico (FSF; f. XIII) in bambini di varie etá sani od affetti da diversi stati morbosi. Pediatria (Napoli) 77, 33–66 (1963).
Barkan, G., Gaspar, A.: Zur Frage der Reversibilität der Fibringerinnung. II. Biochem. Z. 139, 291–301 (1923).
Beck, E., Duckert, F., Ernst, M.: The influence of fibrin stabilizing factor on the growth of fibroblasts in vitro wound healing. Thrombos. Diathes. haemorrh. (Stuttg.) 7, 485–491 (1961).
Biel, H., Bohn, H., Ronneberger, H., Zwisler, O.: Beschleunigung der Wundheilung durch Faktor XIII der Blutgerinnung. Arzneimittel-Forsch. 21, 1429–1430 (1971).
Bitny-Szlachto, S., Kosińska, J., Niedzielska, M.: Determination of sulphydryl groups by means of beta-hydroxyethyl-2,4-dinitrophenyl-disulphide. Acta Pol. pharm. 20, 365–371 (1963).
Bouhasin, J. D., Altay, C.: Factor XIII deficiency. Concentrations in relatives of patients an in normal infants. J. Pediat. 72, 336–341 (1968).
Böhme, H., Stachel, H. D.: Über die Identifizierung von Mercaptanem durch Umsetzung mit 2,4-Dinitro-phenyl-Schwefelchlorid. Z. anal. Chem. 154, 27–33 (1957).
Buluk, K.: An unknown action of blood platelets. Pol. Tyg. lek. 10, 191 (1955).
Buluk, K., Januszko, T., Olbromski, J.: Conversion of fibrin to desmofibrin. Nature (Lond.) 191, 1093–1095 (1961).
Buluk, K., Januszko, T., Olbromski, J., Smrza, M., Cudnik, M.: Erythrocyte fibrin-stabilizing factor. Postępy Hig. Med. dośw. 17, 743–755 (1963).
Buluk, K., Olbromski, J., Januszko, T., Zuch, A.: Desmofibrin formation and the activity of the fibrin stabilizing factor (FSF) during the cleavage of its SH groups by thrombin. Thrombos. Diathes. haemorrh. (Stuttg.) 16, 51–60 (1966).
Buluk, K., Zuch, A.: The possibility of proteolytic activation of fibrin stabilizing factor. Biochim. biophys. Acta (Amst.) 147, 593–595 (1967).
Buluk, K., Zuch, A.: Clinical aspects of the fibrin-stabilizing factor deficiency and the disorders of desmofibrinogenesis. Pol. Arch. Med. wewnęt. 41, 437–443 (1968).
Buluk, K., Zuch, A.: Significance of the thiol groups in the formation of desmofibrin. Pol. Med. J. 10, 886–894 (1971).
Duckert, F., Jung, E., Schmerling, D. H.: A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thrombos. Diathes. haemorrh. (Stuttg.) 5, 179–186 (1960).
Fisher, S., Rikover, M., Naor, S.: Factor XIII deficiency with severe hemorrhagic diathesis. Blood 28, 34–39 (1966).
Fisher, S., Schwarzt, M., Gottlieb, A., Ben Yoseph, N., Shapiro, S.: Fibrinolysis, fibrinogen and factor XIII in newborn infants. Thrombos. Diathes. haemorrh. (Stuttg.) 20, 542–547 (1968).
Godal, H. C.: An inhibitor to fibrin stabilizing factor (FSF, factor XIII). Scand. J. Haemat. 7, 43–48 (1970).
Kiesselbach, T. H., Wagner, R. H.: Fibrin-stabilizing factor: a thrombin-labile platelet protein. Amer. J. Physiol. 211, 1472–1476 (1966).
Kowarzyk, H., Rechnic, M., Siwińska, M., Czerwińska, B.: Bovine blood fibrinolysis and thrombinogenesis. Arch. Immunol. Terap. dośw. 6, 475–488 (1958).
Künzer, W., Lütgemeier, J.: Zur entwicklungsbedingten Abhängigkeit des Plasmagehaltes an Fibrin-stabilisierendem Factor (FSF). Ann. paediat. (Basel) 204, 232–238 (1965).
Laki, K., Lorand, L.: On the solubility of fibrin clots. Science 108, 280 (1948).
Loewy, A. G.: Fibrinase (factor XIII). Thrombos. Diathes. haemorrh. (Stuttg.), Suppl. 13, 108–114 (1964).
Loewy, A. G.: Mechanism of fibrin crosslinkage. Some historical remarks of uncertain objectivity. Thrombos. Diathes. haemorrh. (Stuttg.), Suppl. 39, 103–112 (1970).
Loewy, A. G., Dahlberg, J. E., Dorwart, W. V., Jr., Weber, M. J., Eisele, J.: A transamidase mechanism for insoluble fibrin formation. Biochem. biophys. Res. Commun. 15, 177–181 (1964).
Lorand, L., Jacobsen, A., Bruner-Lorand, J.: A pathological inhibitor of fibrin cross-linking. J. clin. Invest. 47, 268–273 (1968).
Lorand, L., Konishi, K.: Activation of the fibrin stabilizing factor of plasma by thrombin. Arch. Biochem. 105, 58–67 (1964).
Lüscher, E. F.: Ein fibrinstabilisierender Faktor aus Thrombozyten. Schweiz. med. Wschr. 87, 1220–1221 (1957).
Mandel, E. E., Tiongson, T., Tiongson, E.: Acquired plasma fibrin stabilizing factor deficiency and platelets. Fed. Proc. 29, 442 (1970).
McDonagh, J., Kiesselbach, T. H., Wagner, R. H.: Origin of platelet factor XIII (fibrin stabilizing factor). Fed. Proc. 28, 745 (1969).
Nossel, H. L., Lanzkowsky, P., Levy, S., Mibashan, R., Hansen, J.: A study of coagulation factor levels in women during labour and in their newborn infants. Thrombos. Diathes. haemorrh. (Stuttg.) 16, 185–197 (1966).
Nussbaum, M., Morse, B. S.: Plasma fibrin stabilizing factor activity in various diseases. Blood 23, 669–677 (1964).
Oehme, J.: Über die physiologischen Grundlagen der Blutstillung Neugeborener. Mschr. Kinderheilk. 112, 447–452 (1964).
Robbins, K. C. A.: study on the conversion of fibrinogen to fibrin. Amer. J. Physiol. 142, 581–588 (1944).
Schettini, F., Lattanzi, E., Violante, N., Rana, N.: II fattore XIII (fibrin stabilizing factor) nel neonato immaturo. Boll. Soc. ital. Biol. sper. 42, 924–926 (1966).
Sigg, P. E., Duckert, F.: Ein neuer Test zur Bestimmung des fibrinstabilisierenden Faktors. Schweiz. med. Wschr. 93, 1455–1461 (1963).
Ströder, J.: Über den fibrinstabilisierenden Faktor (FSF) in den verschiedenen Lebensabschnitten und bei bestimmten Krankheiten des Kindes. Ann. paediat. (Basel) 203, 393–400 (1964).
Ströder, J.: Über den Gehalt des Plasmas an fibrinstabilisierendem Faktor (FSF) in den verschiedenen Lebensabschnitten. Klin. Wschr. 42, 649–650 (1964).
Ströder, J.: Reduction of fibrin stabilizing factor (FSF) in thrombocytopenia in childhood. Ann. paediat. (Basel) 205, 438–441 (1965).
Ströder, J.: Über fibrinstabilisierenden Faktor in den verschiedenen Lebensabschnitten. Mschr. Kinderheilk. 113, 293–294 (1965).
Violante, N., Paganetti, G., Lattanzi, E., Schettini, F.: II fattore XIII (fibrin stabilizing factor) nel neonato a termine e nel lattane. Boll. Soc. ital. Biol. sper. 43, 535–536 (1967).
Walls, W. D., Losowsky, M. S.: Plasma fibrin stabilizing factor (F.S.F.) activity in normal subjects and patients with chronic liver disease. Thrombos. Diathes. haemorrh. (Stuttg.) 21, 134–143 (1969).
Zuch, A.: Desmofibrinogenic blood activity. Postępy. Hig. Med. dośw. 25, 89–128 (1971).
Author information
Authors and Affiliations
Additional information
Investigation partly subsidized by Department VI of the Polish Academy of Sciences.
Rights and permissions
About this article
Cite this article
Zuch, A., Buluk, K., Rudobielska, M. et al. Variability of actual and potential fibrin-stabilizing factor (FSF) activity of blood plasma in healthy children. Z. Kinder-Heilk. 112, 142–152 (1972). https://doi.org/10.1007/BF00443501
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00443501